Navigation Links
Procedure Lowers 'Hunger Hormone' to Help Obese Lose Weight
Date:3/7/2013

By Steven Reinberg
HealthDay Reporter

THURSDAY, March 7 (HealthDay News) -- The first five patients to try a new, minimally invasive weight-loss procedure dropped an average of more than 45 pounds in six months, researchers report.

The procedure -- called gastric artery chemical embolization (GACE) -- works by blocking an artery in the stomach. This cuts off part of the blood supply to an area of the stomach that produces most of the hormone ghrelin, which stimulates appetite.

"If a large, randomized study shows similar results, this may be a very simple method and an alternative to bariatric surgery," said lead researcher Dr. Nicholas Kipshidze, with New York Cardiovascular Research in New York City.

However, an expert noted that when one hormone is targeted, the body usually finds other ways to compensate. And another expert said the procedure must be studied in far more people for much longer periods to make sure there aren't major complications and that weight loss persists.

The findings were scheduled to be presented Sunday at the annual meeting of the American College of Cardiology, which begins this weekend in San Francisco. The data and conclusions of research presented at meetings should be viewed as preliminary until published in a peer-reviewed journal.

In this first human test, researchers treated five obese people. Patients had a catheter placed in their groin. The catheter was threaded through an artery until it reached the upper part of the stomach, called the gastric fundus. Then, tiny beads were run through the catheter to block the artery.

Although blood flow to the stomach is reduced, the risk of part of the stomach dying from lack of blood is small, because these tissues get blood from other blood vessels, explained Kipshidze, who is also the general director at Republican Hospital in Tbilisi, Georgia.

After a month, patients lost about 29 pounds; by three months they had lost an average of 37 pounds and at six months the average weight loss was 45 pounds, the researchers said.

In addition, ghrelin levels also dropped. After a month, levels had fallen 29 percent, and at three months it had fallen by 36 percent. At six months, however, ghrelin levels were only 18 percent below where they had been before the procedure.

This pattern is one to be expected, according to Dr. David Katz, director of the Yale University Prevention Research Center.

"Ghrelin is one of many hormones known to influence hunger and appetite, and in every prior attempt to change long-term weight outcomes by manipulating one hormone, we found compensatory mechanisms that kick in over time and the benefits tend to wear off," he said.

"So [the new procedure] is unlikely to prove to be an alternative to the lifestyle approaches, namely eating well and being physically active," Katz said.

Study author Kipshidze noted that the new study did not address lifestyle factors. To really test the effectiveness of the procedure, he didn't tell the patients to change their diets or exercise.

"I told them 'Do what you want. Go and eat as much as you want,'" he said. "Their appetite decreased and they simply couldn't eat. Their intake was dramatically decreased."

According to Kipshidze, the procedures went off without a hitch, and so far there have been no complications. The long-term outcomes in terms of sustained weight loss and side effects, however, are still unknown, he said.

Gastric artery chemical embolization has several advantages over current weight-loss procedures, such as gastric bypass surgery and gastric banding, Kipshidze said.

These other procedures are major operations with all the consequences of any operation, including hospital stays and long recovery times, he said. But with this new technique, "You do the procedure in the morning, and you can send the patient home the same day."

He noted that this procedure is a type of gastric artery embolization that has been used for years to treat bleeding in the intestines and reduce side effects from chemotherapy for advanced liver cancer.

Whether there will be complications down the line or whether patients will gain the weight back, as many do after other weight-loss surgery, isn't clear, Kipshidze said.

"Who knows with this procedure whether patients will gain the weight back? I cannot tell you; I don't know what is going to happen," he said.

That answer is the key to whether this procedure will be a viable alternative to other types of weight-loss surgery, another expert said.

"The question is, will this thing work in a lot of people over a long period of time, and what's the complication rate and what's the mortality with it," said Dr. Stephen Green, associate chairman of the department of cardiology at North Shore University Hospital in Manhasset, N.Y.

"If this works, it would be fantastic -- it would be a game changer," he said. "But this is not ready for prime time."

Kipshidze is planning larger clinical trials where some patients -- including some with diabetes -- will undergo the procedure while others will have a sham procedure. In all, they will need to include about 30 patients to be sure the procedure is safe and effective, he said. The procedure is also being refined with new equipment and techniques.

More information

For more about obesity, visit the U.S. National Library of Medicine.

SOURCES: Nicholas Kipshidze, M.D., Ph.D., New York Cardiovascular Research, New York City, and physician-in-chief and general director, Republican Hospital, Tbilisi, Georgia; Stephen Green, M.D., associate chairman, department of cardiology, North Shore University Hospital, Manhasset, N.Y; David Katz, M.D., M.P.H., director, Yale University Prevention Research Center, New Haven, Conn.; March 10, 2013, presentation, American College of Cardiology annual meeting, San Francisco


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. 5 Rheumatology Procedures You Might Not Need
2. Very low risk of infections in advanced brain procedures
3. Ob-Gyn Group Lists Procedures That May Not Be Needed
4. Jacksonville Periodontist, Dr. Richard E. Aguila, Now Fixes High Gum Lines with Crown Lengthening Procedures for His Florida Patients with Excessive Gums Showing
5. Park Cities Aesthetics Demonstrating the Benefits of SmartLipo™ With Their 150th Procedure
6. Controversial Labiaplasty Procedure Receives High Satisfaction Reviews From Patients
7. The Woodlands, TX Periodontist, Dr. Gayle Bradshaw is Now Accepting New Patients For The Modern Bone Graft Procedure To Strengthen Jaw Bone For Dental Implants
8. Dr. Glenn Vallecillos Now Offers Lumenis Total Fx CO2 Fractional Laser Procedure
9. Dr. Robert Barr of Barr Family Dentistry in San Jose, CA Receives Top Reviews for Painless Laser Dental Procedures
10. Instrument handle with integrated electronics facilitates surgical procedures
11. Santa Monica Dermatologist, Dr. Ben Behnam, and Santa Monica Hair Transplant Expert, Dr. Sean Behnam, Launch Their New Websites Focused on Treatment of Acne, Skin Cancer, Laser Procedures and Hair Transplant
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Procedure Lowers 'Hunger Hormone' to Help Obese Lose Weight
(Date:1/21/2017)... ... ... Seamild, the largest manufacturer of oats in China, is now aiming at global ... is recognized globally as one of the healthiest cereals, XieQingkui, the founder of Seamild, ... move to sow the seed of good karma. Buddhism spirit featuring benevolence and sacrifice ...
(Date:1/21/2017)... Pekin, IL (PRWEB) , ... January 21, 2017 , ... ... disorders. Even when individuals experience the freedom of recovery, they often feel shame for ... abuse and post-traumatic stress disorder (PTSD). In the workshop, “Rising Strong in Life After ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and ... essential oils, announced the company had a successful visit to the 2017 ECRM Diet, ... gives companies that work in the nutritional, sports and health industries a chance to ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out ... announced it attended the January ECRM trade show in Hilton Head, SC. , ... was determined to create a line of products that would elevate her fitness regime. ...
(Date:1/20/2017)... ... ... “The Angel”: a heartwarming and earnest tale of faith and believing in the ... is the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, alumnus of ... asked of her new book, Marjorie says, “‘The Angel’ was written as a fairytale, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast to ... ) today announced it will release results for the fourth quarter ... ... host a conference call at 4:30 PM ET on Wednesday, February ... full year 2016 financial results and other corporate activities. To participate ...
(Date:1/19/2017)... , Jan. 19, 2017 This report ... current and future scenario of the global market. Large ... opioid consumption. Severe chronic constipation is a major side ... traditional laxatives. Hence, novel targeted therapy has been prescribed ... sufferers, launch of targeted medicines, and growing awareness about ...
(Date:1/19/2017)...  Stealth BioTherapeutics Inc. ( Stealth ), a clinical-stage ... announced new additions to its senior leadership team: ... and Daniel Geffken as interim Chief Financial ... , Pharm.D. has been promoted to Chief Clinical Development ... Doug and Daniel to our management team, as both ...
Breaking Medicine Technology: